Man Group plc cut its position in Iradimed Corporation (NASDAQ:IRMD - Free Report) by 72.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,772 shares of the medical equipment provider's stock after selling 10,006 shares during the period. Man Group plc's holdings in Iradimed were worth $207,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. R Squared Ltd bought a new stake in shares of Iradimed in the fourth quarter valued at about $30,000. US Bancorp DE boosted its position in Iradimed by 476.6% during the fourth quarter. US Bancorp DE now owns 617 shares of the medical equipment provider's stock worth $34,000 after purchasing an additional 510 shares during the period. Huntington National Bank boosted its holdings in Iradimed by 34.0% in the 4th quarter. Huntington National Bank now owns 1,993 shares of the medical equipment provider's stock valued at $110,000 after purchasing an additional 506 shares during the period. Avantax Advisory Services Inc. bought a new position in shares of Iradimed in the fourth quarter worth approximately $217,000. Finally, Bessemer Group Inc. boosted its stake in Iradimed by 9.6% in the fourth quarter. Bessemer Group Inc. now owns 4,143 shares of the medical equipment provider's stock worth $228,000 after buying an additional 362 shares in the last quarter. 92.34% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of research analysts have issued reports on the stock. Wall Street Zen raised shares of Iradimed from a "buy" rating to a "strong-buy" rating in a research report on Tuesday, May 6th. Roth Mkm reissued a "buy" rating and issued a $72.00 price target (up from $60.00) on shares of Iradimed in a report on Friday, February 14th.
Read Our Latest Stock Report on IRMD
Iradimed Trading Down 0.1%
Shares of NASDAQ:IRMD traded down $0.04 during trading on Friday, reaching $58.10. The stock had a trading volume of 59,181 shares, compared to its average volume of 43,082. The firm's 50-day simple moving average is $52.40 and its 200 day simple moving average is $54.40. The company has a market capitalization of $738.74 million, a P/E ratio of 38.73 and a beta of 0.91. Iradimed Corporation has a one year low of $41.69 and a one year high of $63.29.
Iradimed Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Tuesday, May 20th were issued a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 1.17%. The ex-dividend date of this dividend was Tuesday, May 20th. Iradimed's payout ratio is currently 43.87%.
About Iradimed
(
Free Report)
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.
Featured Articles
Before you consider iRadimed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iRadimed wasn't on the list.
While iRadimed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
